Credit Suisse’s AN2 Therapeutics ANTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$86.5K	Buy	+26,630	New	+$86.5K	﹤0.01%	2931
2022 Q4	–	Sell	-26	Closed	–	–	3936
2022 Q3	$0	Buy	26 +24	+1,200%	–	﹤0.01%	4008
2022 Q2	$0	Buy	+2	New	–	﹤0.01%	3886